Aquinox Pharmaceuticals Company Profile (NASDAQ:AQXP)

About Aquinox Pharmaceuticals

Aquinox Pharmaceuticals logoAquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The Company operates in the segment of identification and development of therapeutics in disease areas of inflammation and immuno-oncology. Its primary focus is anti-inflammatory product candidates targeting the Src Homology 2 (SH2)-containing inositol-5-phosphatase 1 (SHIP1) enzyme, which is a regulator of a cellular signaling pathway in immune cells. The Company's product candidate, AQX-1125, is a small molecule activator of SHIP1 suitable for oral, once daily dosing. The Company is developing AQX-1125 as a treatment in interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic inflammatory disease of the bladder. It has completed and reported results from its Leadership trial, which is a multicenter, randomized, double-blind, placebo-controlled, Phase II clinical trial.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AQXP
  • CUSIP:
Key Metrics:
  • Previous Close: $18.36
  • 50 Day Moving Average: $18.18
  • 200 Day Moving Average: $13.91
  • 52-Week Range: $6.01 - $19.97
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.15
  • P/E Growth: 0.00
  • Market Cap: $428.41M
  • Outstanding Shares: 23,423,000
  • Beta: -17.36
Profitability:
  • Return on Equity: -27.43%
  • Return on Assets: -25.84%
Debt:
  • Current Ratio: 17.13%
  • Quick Ratio: 17.13%
Additional Links:
Companies Related to Aquinox Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Aquinox Pharmaceuticals (NASDAQ:AQXP) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $21.60 (18.10% upside)

Analysts' Ratings History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
Show:
DateFirmActionRatingPrice TargetDetails
12/16/2016Cantor FitzgeraldInitiated CoverageOverweight$28.00View Rating Details
11/11/2016Leerink SwannReiterated RatingBuy$24.00View Rating Details
11/10/2016Needham & Company LLCReiterated RatingBuyView Rating Details
8/17/2016Canaccord GenuityReiterated RatingBuy$22.00View Rating Details
8/5/2016Jefferies Group LLCBoost Price TargetHold$7.00 -> $9.00View Rating Details
11/3/2015Cowen and CompanyReiterated RatingBuy$23.00View Rating Details
10/6/2015GuggenheimInitiated CoverageBuy$22.00View Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/13/2017        
11/9/2016Q316($0.58)($0.46)ViewN/AView Earnings Details
5/10/2016Q1($0.35)($0.39)ViewN/AView Earnings Details
3/14/2016Q4($0.37)($0.26)ViewN/AView Earnings Details
11/10/2015Q315($0.45)($0.43)ViewN/AView Earnings Details
8/6/2015Q215($0.56)($0.44)ViewN/AView Earnings Details
5/12/2015Q115($0.83)($0.60)ViewN/AView Earnings Details
4/15/2015($0.57)($0.78)ViewN/AView Earnings Details
3/16/2015($0.76)($0.78)ViewN/AView Earnings Details
11/4/2014($0.29)($0.59)ViewN/AView Earnings Details
8/11/2014($0.27)($0.51)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aquinox Pharmaceuticals (NASDAQ:AQXP)
Current Year EPS Consensus Estimate: $-2.03 EPS
Next Year EPS Consensus Estimate: $-2.00 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.38)($0.31)($0.35)
Q2 20162($0.47)($0.42)($0.45)
Q3 20162($0.58)($0.45)($0.52)
Q4 20162($0.56)($0.49)($0.53)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
Insider Ownership Percentage: 3.00%
Institutional Ownership Percentage: 97.78%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/9/2017Bros. Advisors Lp BakerMajor ShareholderBuy398,062$17.18$6,838,705.16View SEC Filing  
9/20/2016Bros. Advisors Lp BakerMajor ShareholderBuy2,783,605$12.25$34,099,161.25View SEC Filing  
3/16/2016Bros. Advisors Lp BakerMajor ShareholderBuy471,667$7.99$3,768,619.33View SEC Filing  
3/15/2016Bros. Advisors Lp BakerMajor ShareholderBuy109,912$7.98$877,097.76View SEC Filing  
1/26/2016Bros. Advisors Lp BakerMajor ShareholderBuy140,786$10.80$1,520,488.80View SEC Filing  
1/20/2016Bros. Advisors Lp BakerMajor ShareholderBuy112,034$9.48$1,062,082.32View SEC Filing  
1/19/2016Bros. Advisors Lp BakerMajor ShareholderBuy78,045$9.11$710,989.95View SEC Filing  
1/15/2016Bros. Advisors Lp BakerMajor ShareholderBuy202,623$8.28$1,677,718.44View SEC Filing  
9/10/2015Bros. Advisors Lp BakerMajor ShareholderBuy2,480,032$15.50$38,440,496.00View SEC Filing  
8/24/2015David Chilton MitchellVPBuy3,575$17.81$63,670.75View SEC Filing  
8/12/2015Kamran AlamCFOSell29,079$18.67$542,904.93View SEC Filing  
8/12/2015Lloyd MackenzieVPSell35,887$18.67$670,010.29View SEC Filing  
12/17/2014& Johnson JohnsonMajor ShareholderSell8,100$7.62$61,722.00View SEC Filing  
12/12/2014& Johnson JohnsonMajor ShareholderSell5,000$7.51$37,550.00View SEC Filing  
12/10/2014& Johnson JohnsonMajor ShareholderSell8,300$7.72$64,076.00View SEC Filing  
12/9/2014& Johnson JohnsonMajor ShareholderSell5,000$7.73$38,650.00View SEC Filing  
12/8/2014& Johnson JohnsonMajor ShareholderSell2,000$7.69$15,380.00View SEC Filing  
12/5/2014& Johnson JohnsonMajor ShareholderSell15,900$7.76$123,384.00View SEC Filing  
12/1/2014& Johnson JohnsonMajor ShareholderSell1,200$7.54$9,048.00View SEC Filing  
11/26/2014& Johnson JohnsonMajor ShareholderSell2,000$7.75$15,500.00View SEC Filing  
11/24/2014& Johnson JohnsonMajor ShareholderSell9,500$8.14$77,330.00View SEC Filing  
3/12/2014Pfizer IncMajor ShareholderBuy272,727$11.00$2,999,997.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aquinox Pharmaceuticals (NASDAQ:AQXP)
DateHeadline
News IconAnalysts Peer Into Their Crystal Balls For Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Where Is It headed? - Winfield Review (NASDAQ:AQXP)
winfieldreview.com - February 21 at 8:47 AM
News IconAquinox Pharmaceuticals Inc AQXP Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:AQXP)
www.bioportfolio.com - February 19 at 8:12 AM
News IconEarnings Wrap Up & Price Target Focus on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Winfield Review (NASDAQ:AQXP)
winfieldreview.com - February 16 at 8:32 AM
News IconAre Insiders Stocking Up on Their Own Shares? Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Update - Winfield Review (NASDAQ:AQXP)
winfieldreview.com - February 13 at 9:04 PM
News IconAnalyst Target Review on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Rockville Register (NASDAQ:AQXP)
rockvilleregister.com - February 13 at 9:04 PM
News IconAquinox to Present at Leerink Partners 6th Annual Global Healthcare Conference - EconoTimes (NASDAQ:AQXP)
www.econotimes.com - February 9 at 3:41 PM
News IconChecking the Metrics on Shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Davidson Register (NASDAQ:AQXP)
davidsonregister.com - February 9 at 3:41 PM
finance.yahoo.com logoAquinox to Present at Leerink Partners 6th Annual Global Healthcare Conference (NASDAQ:AQXP)
finance.yahoo.com - February 9 at 3:41 PM
News IconBrokerage Consensus Update: El Pollo Loco Holdings, Inc. (NASDAQ:LOCO) Aquinox Pharmaceuticals, Inc. (NASDAQ ... - The Standard (NASDAQ:AQXP)
6milestandard.com - February 8 at 8:50 PM
News IconMarket Sheet: Watching the Levels for Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Searcy News (NASDAQ:AQXP)
searcysentinel.com - February 8 at 3:50 PM
News IconAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Quarterly EPS Projection At $-0.63 - Stock Observer (NASDAQ:AQXP)
www.thestockobserver.com - February 3 at 8:48 PM
News IconEarnings Parade Rolls On, What Are Analysts Saying About Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP)? - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - February 1 at 3:43 PM
News IconEarnings Snapshot & Analysts Target Update on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP)? - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - January 31 at 8:48 PM
News IconWhat The Charts Are Saying About Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Gilbert Daily (NASDAQ:AQXP)
gilbertdaily.com - January 31 at 3:48 PM
News IconAre Insiders Bumping Up Their Positions in Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - January 31 at 3:48 PM
News IconPeeling Back The Layers on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Analysts & Street Weigh In - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - January 31 at 3:48 PM
News IconIs There Inherent Value in Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP)? Analysts Delve Into The Stock - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - January 27 at 9:28 PM
News IconConsensus Take: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Earnings & Ratings Watch - Aiken Advocate (NASDAQ:AQXP)
aikenadvocate.com - January 27 at 4:26 PM
News IconKeeping Tabs on Levels for Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Gilbert Daily (NASDAQ:AQXP)
gilbertdaily.com - January 27 at 4:26 PM
News IconAnalysts Peering Into Their Crystal Balls, What's the Sentiment on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - January 26 at 8:59 PM
News IconTechnical Buzz on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Gilbert Daily (NASDAQ:AQXP)
gilbertdaily.com - January 26 at 3:55 PM
News IconInvestor Watch: Checking in on Shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Gilbert Daily (NASDAQ:AQXP)
gilbertdaily.com - January 25 at 3:41 PM
News IconEarnings in Full Force, Analysts Take Aim at Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - January 25 at 3:41 PM
News IconKeeping an Eye on Shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Gilbert Daily (NASDAQ:AQXP)
gilbertdaily.com - January 24 at 3:54 PM
News IconAnalysts Pounding The Pavement on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Consensus Update - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - January 23 at 8:42 PM
News IconAnalysts Pull Back the Curtain on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Consensus Update - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - January 21 at 3:33 PM
News IconAquinox Pharmaceuticals Inc AQXP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:AQXP)
www.bioportfolio.com - January 18 at 2:20 AM
News IconWall Street and Armchair Analysts Weigh in on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Heading Into The New ... - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - January 17 at 9:58 AM
News IconTracking Corporate Insiders: What Are They Doing With Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - January 17 at 9:58 AM
News IconShort Interest Worth Mentioning Today: Aquinox Pharmaceuticals ... - Baxley Report (NASDAQ:AQXP)
baxleyreport.com - January 15 at 3:33 PM
News IconPrimed For An Earnings Beat? Sell-side Chimes in on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Stock - Wall Street Beacon (NASDAQ:AQXP)
wsbeacon.com - January 13 at 9:05 PM
News IconEPS Of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) At $-0.63 - Stock Observer (NASDAQ:AQXP)
www.thestockobserver.com - January 13 at 9:05 PM
thestreet.com logo5 Stocks Insiders Love Right Now (NASDAQ:AQXP)
www.thestreet.com - January 13 at 4:04 PM
investornewswire.com logoSentiments And Ratings Alert: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Investor Newswire (NASDAQ:AQXP)
www.investornewswire.com - January 11 at 3:50 PM
News IconNews Impact Score Of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Set At 0 - Stock Observer (NASDAQ:AQXP)
www.thestockobserver.com - January 11 at 3:50 PM
finance.yahoo.com logoCan The Uptrend Continue for Aquinox Pharmaceuticals (AQXP)? - Yahoo Finance (NASDAQ:AQXP)
finance.yahoo.com - January 10 at 3:39 PM
News IconAquinox Pharmaceuticals, Inc. (AQXP) Under Analyst Spotlight - UK ... - UK Market News (NASDAQ:AQXP)
www.ukmarketnews.co.uk - January 5 at 3:53 PM
News IconBroker Changes For Aquinox Pharmaceuticals, Inc. (AQXP) - NewsDen (NASDAQ:AQXP)
newsden.net - December 31 at 3:34 PM
News IconAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) EPS At $-0.63 - Stock Observer (NASDAQ:AQXP)
www.thestockobserver.com - December 31 at 1:56 AM
investornewswire.com logoAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Records An Impact Score Of 0 - Investor Newswire (NASDAQ:AQXP)
www.investornewswire.com - December 28 at 8:37 AM
News IconEPS Of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Set At ... - Stock Observer (NASDAQ:AQXP)
www.thestockobserver.com - December 23 at 8:41 PM
insidermonkey.com logoIs Aquinox Pharmaceuticals Inc (AQXP) A Good Stock To Buy? (NASDAQ:AQXP)
www.insidermonkey.com - December 19 at 1:38 AM
marketexclusive.com logoAnalyst Activity – Cantor Fitzgerald Initiates Coverage On Aquinox Pharmaceuticals (NASDAQ:AQXP) With a Overweight (NASDAQ:AQXP)
marketexclusive.com - December 17 at 9:00 PM
News IconLong Term Growth review of American Airlines Group, Inc. (NASDAQ:AAL) (NASDAQ:AQXP)
diy-home-garden.com - December 17 at 3:40 PM
benzinga.com logoAquinox Pharmaceuticals Sellers Feast On Cantor Fitzgerald Overweight Rating (NASDAQ:AQXP)
www.benzinga.com - December 17 at 1:42 AM
News IconInvestor Review: Focusing in on Shares of Aquinox Pharmaceuticals Inc. (AQXP) - StockTalk Daily (NASDAQ:AQXP)
stocktalkdaily.com - December 16 at 3:40 PM
finance.yahoo.com logoCoverage initiated on Aquinox Pharma by Cantor Fitzgerald (NASDAQ:AQXP)
finance.yahoo.com - December 16 at 3:40 PM
finance.yahoo.com logoCan The Uptrend Continue for Aquinox Pharmaceuticals (AQXP)? (NASDAQ:AQXP)
finance.yahoo.com - December 16 at 3:40 PM
capitalcube.com logoAquinox Pharmaceuticals, Inc. :AQXP-US: Earnings Analysis: Q3, 2016 By the Numbers : December 15, 2016 (NASDAQ:AQXP)
www.capitalcube.com - December 15 at 4:03 PM
News IconEPS Of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Set At $-0.63 - Stock Observer (NASDAQ:AQXP)
www.thestockobserver.com - December 9 at 3:39 PM

Social

What is Aquinox Pharmaceuticals' stock symbol?

Aquinox Pharmaceuticals trades on the NASDAQ under the ticker symbol "AQXP."

Where is Aquinox Pharmaceuticals' stock going? Where will Aquinox Pharmaceuticals' stock price be in 2017?

5 equities research analysts have issued 1-year price objectives for Aquinox Pharmaceuticals' stock. Their predictions range from $9.00 to $28.00. On average, they anticipate Aquinox Pharmaceuticals' stock price to reach $21.60 in the next year.

When will Aquinox Pharmaceuticals announce their earnings?

Aquinox Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.

Who owns Aquinox Pharmaceuticals stock?

Aquinox Pharmaceuticals' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Franklin Resources Inc. (5.94%), Boxer Capital LLC (3.75%), Alyeska Investment Group L.P. (1.17%), Eventide Asset Management LLC (0.75%), Royce & Associates LP (0.68%) and State Street Corp (0.05%). Company insiders that own Aquinox Pharmaceuticals stock include Bros Advisors Lp Baker, David Chilton Mitchell, Kamran Alam and Lloyd Mackenzie.

Who sold Aquinox Pharmaceuticals stock? Who is selling Aquinox Pharmaceuticals stock?

Aquinox Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc. and Royce & Associates LP.

Who bought Aquinox Pharmaceuticals stock? Who is buying Aquinox Pharmaceuticals stock?

Aquinox Pharmaceuticals' stock was acquired by a variety of institutional investors in the last quarter, including Eventide Asset Management LLC and Alyeska Investment Group L.P.. Company insiders that have bought Aquinox Pharmaceuticals stock in the last two years include Bros Advisors Lp Baker and David Chilton Mitchell.

How do I buy Aquinox Pharmaceuticals stock?

Shares of Aquinox Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Aquinox Pharmaceuticals stock cost?

One share of Aquinox Pharmaceuticals stock can currently be purchased for approximately $18.29.

Aquinox Pharmaceuticals (NASDAQ:AQXP) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Aquinox Pharmaceuticals (NASDAQ:AQXP)

Earnings History Chart

Earnings by Quarter for Aquinox Pharmaceuticals (NASDAQ:AQXP)

Dividend History Chart

Dividend Payments by Quarter for Aquinox Pharmaceuticals (NASDAQ:AQXP)

Last Updated on 2/21/2017 by MarketBeat.com Staff